Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Mitsubishi describes synthesis and activity of MKC-242

Sep. 15, 1997

Novel neuroprotective agent developed at Takeda

Sep. 15, 1997

Novartis evaluates SDZ-267-489 and analogues for increasing HDL cholesterol

Sep. 15, 1997

Novel antibacterial agents from R.W. Johnson

Sep. 15, 1997

Potent GH secretagogues synthesized at Merck & Co.

Sep. 15, 1997

New trinem reported by SRI

Sep. 12, 1997

DuPont Merck presents dual MMP/TNF-alpha-converting enzyme inhibitor

Sep. 12, 1997

L-374087: a new thrombin inhibitor developed at Merck & Co.

Sep. 12, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...